UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000031233
Receipt number R000035663
Scientific Title A clinical study of CapeOX+Cetuximab as first line therapy in patents with KRAS/BRAF wild type metastatic colorectal cancer (A pooled analysis of FLEET and FLEET2 study)
Date of disclosure of the study information 2018/03/01
Last modified on 2018/02/09 19:19:39

No. Disposal Last modified on Item of update
1 Insert 2018/02/09 19:20:27